998 related articles for article (PubMed ID: 18183615)
1. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
3. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
4. The modulation of protein kinase A and heat shock protein 70 is involved in the reversible increase of blood-brain tumor barrier permeability induced by papaverine.
Wang ZH; Xue YX; Liu YH
Brain Res Bull; 2010 Nov; 83(6):367-73. PubMed ID: 20728510
[TBL] [Abstract][Full Text] [Related]
5. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
[TBL] [Abstract][Full Text] [Related]
6. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Xie H; Liu LB
J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma.
Zhang Z; Xue Y; Liu Y; Shang X
Neurosci Lett; 2010 Aug; 481(1):21-5. PubMed ID: 20600613
[TBL] [Abstract][Full Text] [Related]
8. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
Gu YT; Xue YX; Wei XY; Zhang H; Li Y
Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
[TBL] [Abstract][Full Text] [Related]
9. Effects of combining low frequency ultrasound irradiation with papaverine on the permeability of the blood-tumor barrier.
Wang JE; Liu YH; Liu LB; Xia CY; Zhang Z; Xue YX
J Neurooncol; 2011 Apr; 102(2):213-24. PubMed ID: 20683758
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin.
Liu LB; Liu XB; Ma J; Liu YH; Li ZQ; Ma T; Zhao XH; Xi Z; Xue YX
Biochem Biophys Res Commun; 2015 Aug; 464(1):118-25. PubMed ID: 26106824
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.
Ma J; Wang P; Liu Y; Zhao L; Li Z; Xue Y
J Cell Physiol; 2014 Jul; 229(7):916-26. PubMed ID: 24318462
[TBL] [Abstract][Full Text] [Related]
12. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
Duan M; Xing Y; Guo J; Chen H; Zhang R
Pharm Biol; 2016 Dec; 54(12):3009-3018. PubMed ID: 27431008
[TBL] [Abstract][Full Text] [Related]
13. The role of histamine in opening blood-tumor barrier.
Wang Z; Cai XJ; Qin J; Xie FJ; Han N; Lu HY
Oncotarget; 2016 May; 7(21):31299-310. PubMed ID: 27121317
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells.
Lee HS; Namkoong K; Kim DH; Kim KJ; Cheong YH; Kim SS; Lee WB; Kim KY
Microvasc Res; 2004 Nov; 68(3):231-8. PubMed ID: 15501242
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
Zhang H; Gu YT; Xue YX
Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
17. Permeability of the blood-tumor barrier is enhanced by combining vascular endothelial growth factor with papaverine.
Yang ZH; Liu LB; Zhao LN; Liu YH; Xue YX
J Neurosci Res; 2014 Jun; 92(6):703-13. PubMed ID: 24523141
[TBL] [Abstract][Full Text] [Related]
18. RhoA-mediated potential regulation of blood-tumor barrier permeability by bradykinin.
Ma T; Xue Y
J Mol Neurosci; 2010 Sep; 42(1):67-73. PubMed ID: 20369389
[TBL] [Abstract][Full Text] [Related]
19. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5.
Miao YS; Zhao YY; Zhao LN; Wang P; Liu YH; Ma J; Xue YX
Cell Signal; 2015 Jan; 27(1):156-67. PubMed ID: 25452107
[TBL] [Abstract][Full Text] [Related]
20. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
Nag S; Venugopalan R; Stewart DJ
Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
